Hepatitis C Virus (HCV) Infection Withdrawn Phase 2 Trials for BMS-986094 (DB11966)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01629732Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis CTreatment